Ziad Joha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ziad Joha has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Ayşegül Öztürk
Departments of Medical Services and Techniques, Vocational School of Health Services, Sivas Cumhuriyet University, Sivas, Turkey
5 shared publications- Ahmet Sevki Taskiran
Sivas Cumhuriyet University School of Medicine
3 shared publications Ahmet Şevki Taşkıran
Departments of Physiology, School of Medicine, Cumhuriyet University, Sivas, Turkey
3 shared publicationsFatih Yulak
Department of Physiology, School of Medicine, Sivas Cumhuriyet University, Sivas, Turkey
3 shared publications- Levent Hacisüleyman
Fenerbahçe Üniversitesi
3 shared publications Mustafa Özkaraca
Faculty of Veterinary Medicine, Department of Pathology, Sivas Cumhuriyet University, Sivas, Turkiye
3 shared publications
Latest Publications
- 15 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
NaHS inhibits cell proliferation by enhancing oxidative stress and apoptosis in HCT116 cells.
Colorectal cancer remains a leading cause of cancer-related mortality, and current treatments are often limited by toxicity and therapeutic resistance. This study investigated the antiproliferative effects of the fast-releasing hydrogen sulfide (H₂S) donor sodium hydrosulfide (NaHS) in HCT116 colorectal cancer cells and explored the underlying mechanisms related to oxidative stress, DNA damage, apoptosis, inflammation, and key growth-related signaling pathways. HCT116 colorectal cancer cells and CCD-18Co normal colon fibroblast cells were cultured under standard conditions and treated with increasing concentrations of sodium hydrosulfide (NaHS). Cell viability was assessed using the XTT assay to determine antiproliferative activity and half-maximal inhibitory concentration (IC₅₀) values. Oxidative stress was evaluated by measuring total antioxidant status (TAS), total oxidant status (TOS), and intracellular reactive oxygen species (ROS) generation. Apoptosis and signaling-related proteins were analyzed by enzyme-linked immunosorbent assay (ELISA)-based quantification of BCL2-associated agonist of cell death (BAD), caspase-3, B-cell lymphoma 2 (BCL-2), phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-κB), supported by Annexin V flow cytometry. Oxidative DNA damage and apoptotic activation were further evaluated using immunofluorescence staining for 8-hydroxy-2'-deoxyguanosine (8-OHdG) and cleaved caspase-3. NaHS significantly reduced HCT116 cell viability in a concentration- and time-dependent manner, with IC₅₀ values of 4.56, 2.549, and 1.688 mM after 24, 48, and 72 h of treatment, respectively. In contrast, lower concentrations of NaHS did not significantly affect the viability of CCD-18Co normal colon fibroblast cells. NaHS treatment induced oxidative stress, as evidenced by decreased TAS, increased TOS, and elevated intracellular ROS levels. Apoptotic responses were associated with increased BAD and caspase-3 levels, decreased BCL-2 expression, and increased early and late apoptotic cell populations. NaHS also increased 8-OHdG and cleaved caspase-3 immunofluorescence signals. In addition, reduced levels of PI3K-, MAPK-, and NF-κB-related proteins were observed following NaHS treatment. NaHS exerts potent antiproliferative effects in colorectal cancer cells by inducing oxidative stress-mediated apoptosis and inhibiting key survival and inflammatory signaling pathways.
- 15 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
NaHS inhibits cell proliferation by enhancing oxidative stress and apoptosis in HCT116 cells.
Colorectal cancer remains a leading cause of cancer-related mortality, and current treatments are often limited by toxicity and therapeutic resistance. This study investigated the antiproliferative effects of the fast-releasing hydrogen sulfide (H₂S) donor sodium hydrosulfide (NaHS) in HCT116 colorectal cancer cells and explored the underlying mechanisms related to oxidative stress, DNA damage, apoptosis, inflammation, and key growth-related signaling pathways. HCT116 colorectal cancer cells and CCD-18Co normal colon fibroblast cells were cultured under standard conditions and treated with increasing concentrations of sodium hydrosulfide (NaHS). Cell viability was assessed using the XTT assay to determine antiproliferative activity and half-maximal inhibitory concentration (IC₅₀) values. Oxidative stress was evaluated by measuring total antioxidant status (TAS), total oxidant status (TOS), and intracellular reactive oxygen species (ROS) generation. Apoptosis and signaling-related proteins were analyzed by enzyme-linked immunosorbent assay (ELISA)-based quantification of BCL2-associated agonist of cell death (BAD), caspase-3, B-cell lymphoma 2 (BCL-2), phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-κB), supported by Annexin V flow cytometry. Oxidative DNA damage and apoptotic activation were further evaluated using immunofluorescence staining for 8-hydroxy-2'-deoxyguanosine (8-OHdG) and cleaved caspase-3. NaHS significantly reduced HCT116 cell viability in a concentration- and time-dependent manner, with IC₅₀ values of 4.56, 2.549, and 1.688 mM after 24, 48, and 72 h of treatment, respectively. In contrast, lower concentrations of NaHS did not significantly affect the viability of CCD-18Co normal colon fibroblast cells. NaHS treatment induced oxidative stress, as evidenced by decreased TAS, increased TOS, and elevated intracellular ROS levels. Apoptotic responses were associated with increased BAD and caspase-3 levels, decreased BCL-2 expression, and increased early and late apoptotic cell populations. NaHS also increased 8-OHdG and cleaved caspase-3 immunofluorescence signals. In addition, reduced levels of PI3K-, MAPK-, and NF-κB-related proteins were observed following NaHS treatment. NaHS exerts potent antiproliferative effects in colorectal cancer cells by inducing oxidative stress-mediated apoptosis and inhibiting key survival and inflammatory signaling pathways.
- 29 April 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (2) , 202-207
Antiproliferative Effects of Galium Aparine in SNU-1 Gastric Cancer Cells and Its Association with Growth Signaling Pathways
Galium aparine (G. aparine) is a plant with a long history of ethnopharmacological use and has been investigated for various biological activities, including potential anticancer effects. The present study aimed to investigate the in vitro effects of G. aparine extract on SNU-1 human gastric carcinoma cells and to examine its potential role in the inhibition of cell proliferation. Our experimental setup involved exposing SNU-1 cells to G. aparine (12.5–200 µg/mL) for 24 hours. Cell viability was then evaluated using the XTT assay, and ELISA measured the levels of growth signal factors mTOR, HER-2, EGFR, and ERK-1/2. The XTT assay revealed a significant reduction in cell viability (p<0.001). Furthermore, ELISA measurements showed that G. aparine treatment notably decreased the levels of crucial growth signal factors, including mTOR, HER-2, EGFR, and ERK-1/2 (p<0.05 to p<0.01). These findings suggest that the antiproliferative activity of Galium aparine against gastric cancer cells may be associated with the modulation of key growth signaling pathways involved in cancer cell survival and proliferation. This highlights the potential of G. aparine as a natural agent that could be further investigated as a complementary or alternative approach for gastric cancer research.
- 29 April 2026
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 47 (2) , 202-207
Antiproliferative Effects of Galium Aparine in SNU-1 Gastric Cancer Cells and Its Association with Growth Signaling Pathways
Galium aparine (G. aparine) is a plant with a long history of ethnopharmacological use and has been investigated for various biological activities, including potential anticancer effects. The present study aimed to investigate the in vitro effects of G. aparine extract on SNU-1 human gastric carcinoma cells and to examine its potential role in the inhibition of cell proliferation. Our experimental setup involved exposing SNU-1 cells to G. aparine (12.5–200 µg/mL) for 24 hours. Cell viability was then evaluated using the XTT assay, and ELISA measured the levels of growth signal factors mTOR, HER-2, EGFR, and ERK-1/2. The XTT assay revealed a significant reduction in cell viability (p<0.001). Furthermore, ELISA measurements showed that G. aparine treatment notably decreased the levels of crucial growth signal factors, including mTOR, HER-2, EGFR, and ERK-1/2 (p<0.05 to p<0.01). These findings suggest that the antiproliferative activity of Galium aparine against gastric cancer cells may be associated with the modulation of key growth signaling pathways involved in cancer cell survival and proliferation. This highlights the potential of G. aparine as a natural agent that could be further investigated as a complementary or alternative approach for gastric cancer research.
- 27 February 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (3) , 1461-1474
Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and β-Glucan in Colon and Gastric Cancer Cells
Colon and gastric cancers are among the most prevalent gastrointestinal malignancies, often exhibiting poor prognosis due to resistance and recurrence. Polo-like kinase 1 (PLK1), a key regulator of mitosis, is frequently overexpressed in these cancers. BI-2536, a selective PLK1 inhibitor, has shown promising anticancer activity. β-Glucan, a natural immunomodulator, has also demonstrated anticancer potential. This study aimed to evaluate the antiproliferative, apoptotic, and cell cycle effects of BI-2536 alone and in combination with β-glucan on HT-29 colon and AGS gastric cancer cell lines. Cell viability was assessed using the XTT assay. Apoptosis and cell cycle profiles were evaluated using flow cytometry. The combination index (CI) was calculated using the Chou-Talalay method via CompuSyn software. BI-2536 significantly inhibited proliferation and induced G2/M arrest and apoptosis in both cell lines. β-Glucan showed moderate cytotoxicity and enhanced BI-2536's effects. Synergistic antiproliferative activity was observed at lower drug concentrations, such as 2-16 nM BI-2536 combined with 31.25-250 μg/ml β-glucan (CI2/M arrest compared with either agent alone, demonstrating a clear synergistic effect. BI-2536 in combination with β-glucan exhibits synergistic anticancer effects in vitro, suggesting a promising strategy for treating colon and gastric cancers.
- 27 February 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (3) , 1461-1474
Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and β-Glucan in Colon and Gastric Cancer Cells
Colon and gastric cancers are among the most prevalent gastrointestinal malignancies, often exhibiting poor prognosis due to resistance and recurrence. Polo-like kinase 1 (PLK1), a key regulator of mitosis, is frequently overexpressed in these cancers. BI-2536, a selective PLK1 inhibitor, has shown promising anticancer activity. β-Glucan, a natural immunomodulator, has also demonstrated anticancer potential. This study aimed to evaluate the antiproliferative, apoptotic, and cell cycle effects of BI-2536 alone and in combination with β-glucan on HT-29 colon and AGS gastric cancer cell lines. Cell viability was assessed using the XTT assay. Apoptosis and cell cycle profiles were evaluated using flow cytometry. The combination index (CI) was calculated using the Chou-Talalay method via CompuSyn software. BI-2536 significantly inhibited proliferation and induced G2/M arrest and apoptosis in both cell lines. β-Glucan showed moderate cytotoxicity and enhanced BI-2536's effects. Synergistic antiproliferative activity was observed at lower drug concentrations, such as 2-16 nM BI-2536 combined with 31.25-250 μg/ml β-glucan (CI2/M arrest compared with either agent alone, demonstrating a clear synergistic effect. BI-2536 in combination with β-glucan exhibits synergistic anticancer effects in vitro, suggesting a promising strategy for treating colon and gastric cancers.
- Open Access
- 11 August 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (8) , e70441
Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells
Proton pump inhibitors (PPIs), including esomeprazole, impact the acidic tumor microenvironment, potentially influencing cancer cell behavior. By examining the combined effects of esomeprazole and cisplatin on SNU‐1 gastric carcinoma cells, this study sought to elucidate the mechanisms through which esomeprazole enhances cisplatin's cytotoxicity, potentially allowing for effective treatment with reduced cisplatin dosages. SNU‐1 cells were treated with varying doses of esomeprazole and cisplatin, alone and in combination. Cell viability was assessed using the XTT assay. Oxidative stress (TAS/TOS), apoptosis (Annexin V, cleaved PARP), mitochondrial membrane potential, and DNA damage (8‐oxo‐dG, γH2AX, ATM) were evaluated using flow cytometry and ELISA. Statistical significance was determined by ANOVA. Esomeprazole alone showed no significant effect on SNU‐1 cell viability, oxidative stress (TAS/TOS), apoptosis, mitochondrial membrane potential, or DNA damage. Cisplatin, however, significantly reduced cell viability (IC50 = 3.024 µg/mL), increased oxidative stress (decreased TAS, increased TOS), diminished apoptosis (increased Annexin V binding and cleaved PARP levels), disrupted mitochondrial membrane potential, and caused significant DNA damage (increased H2AX and ATM phosphorylation, and elevated 8‐oxo‐dG) ( p < 0.001). Notably, the combination of esomeprazole and cisplatin synergistically enhanced cisplatin's effects. The combination resulted in a significantly greater reduction in cell viability (CI < 1), a further increase in oxidative stress, a higher level of apoptosis, amplified mitochondrial depolarization, and potentiated DNA damage compared to cisplatin alone ( p < 0.001). Esomeprazole potentiates cisplatin‐induced cytotoxicity in SNU‐1 gastric cancer cells by enhancing oxidative stress, apoptosis, mitochondrial dysfunction, and DNA damage. This suggests a potential therapeutic strategy to improve cisplatin efficacy and overcome resistance in gastric cancer.
- 11 August 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (8) , e70441
Open AccessEsomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells
Proton pump inhibitors (PPIs), including esomeprazole, impact the acidic tumor microenvironment, potentially influencing cancer cell behavior. By examining the combined effects of esomeprazole and cisplatin on SNU‐1 gastric carcinoma cells, this study sought to elucidate the mechanisms through which esomeprazole enhances cisplatin's cytotoxicity, potentially allowing for effective treatment with reduced cisplatin dosages. SNU‐1 cells were treated with varying doses of esomeprazole and cisplatin, alone and in combination. Cell viability was assessed using the XTT assay. Oxidative stress (TAS/TOS), apoptosis (Annexin V, cleaved PARP), mitochondrial membrane potential, and DNA damage (8‐oxo‐dG, γH2AX, ATM) were evaluated using flow cytometry and ELISA. Statistical significance was determined by ANOVA. Esomeprazole alone showed no significant effect on SNU‐1 cell viability, oxidative stress (TAS/TOS), apoptosis, mitochondrial membrane potential, or DNA damage. Cisplatin, however, significantly reduced cell viability (IC50 = 3.024 µg/mL), increased oxidative stress (decreased TAS, increased TOS), diminished apoptosis (increased Annexin V binding and cleaved PARP levels), disrupted mitochondrial membrane potential, and caused significant DNA damage (increased H2AX and ATM phosphorylation, and elevated 8‐oxo‐dG) ( p < 0.001). Notably, the combination of esomeprazole and cisplatin synergistically enhanced cisplatin's effects. The combination resulted in a significantly greater reduction in cell viability (CI < 1), a further increase in oxidative stress, a higher level of apoptosis, amplified mitochondrial depolarization, and potentiated DNA damage compared to cisplatin alone ( p < 0.001). Esomeprazole potentiates cisplatin‐induced cytotoxicity in SNU‐1 gastric cancer cells by enhancing oxidative stress, apoptosis, mitochondrial dysfunction, and DNA damage. This suggests a potential therapeutic strategy to improve cisplatin efficacy and overcome resistance in gastric cancer.
- 25 February 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 83 (3) , 3215-3223
Bromelain Protects Against PTZ-Induced Glial Damage and Inflammation: An In Vitro and In Silico Study
This study aimed to investigate how bromelain protects glial cells from pentylenetetrazole (PTZ)-induced damage, focusing on its anti-inflammatory effects. C6 glioma cells were treated with PTZ, bromelain, or a combination of PTZ and bromelain. The interactions of bromelain with iNOS (Inducible Nitric Oxide Synthase) and COX2 (Cyclooxygenase-2) were investigated using molecular docking calculations. Cell viability was measured using the XTT (Methoxynitrosulfophenyl-Tetrazolium Carboxanilide) assay. iNOS, NO (Nitric Oxide), and COX2 levels were assessed using ELISA and immunofluorescence staining. Bromelain at 50 and 100 µg/mL significantly increased cell viability (p < 0.001). On the other hand, bromelain at 50 µg/mL reduced inflammation, as indicated by lower levels of NO, iNOS, and COX2 (p < 0.001). In-silico predictions suggest that bromelain can effectively target iNOS and COX2, key inflammatory proteins. These findings indicate that bromelain protects glial cells by exerting anti-inflammatory effects. However, further research is needed to understand the underlying mechanisms fully. Graphical Abstract
- 25 February 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 83 (3) , 3215-3223
Bromelain Protects Against PTZ-Induced Glial Damage and Inflammation: An In Vitro and In Silico Study
This study aimed to investigate how bromelain protects glial cells from pentylenetetrazole (PTZ)-induced damage, focusing on its anti-inflammatory effects. C6 glioma cells were treated with PTZ, bromelain, or a combination of PTZ and bromelain. The interactions of bromelain with iNOS (Inducible Nitric Oxide Synthase) and COX2 (Cyclooxygenase-2) were investigated using molecular docking calculations. Cell viability was measured using the XTT (Methoxynitrosulfophenyl-Tetrazolium Carboxanilide) assay. iNOS, NO (Nitric Oxide), and COX2 levels were assessed using ELISA and immunofluorescence staining. Bromelain at 50 and 100 µg/mL significantly increased cell viability (p < 0.001). On the other hand, bromelain at 50 µg/mL reduced inflammation, as indicated by lower levels of NO, iNOS, and COX2 (p < 0.001). In-silico predictions suggest that bromelain can effectively target iNOS and COX2, key inflammatory proteins. These findings indicate that bromelain protects glial cells by exerting anti-inflammatory effects. However, further research is needed to understand the underlying mechanisms fully. Graphical Abstract
- Open Access
- 30 December 2024
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 45 (4) , 683-687
Oxidative Stress Mediates Anti-proliferative Effects of Nifedipine on AGS Cells
Previous studies have demonstrated the anticancer properties of certain calcium channel blockers when administered as sole agents. This exploration aimed to explore the potential anti-proliferative activity of nifedipine on AGS gastric cancer cells and to determine the contribution of oxidative stress in mediating this response. To assess the anti-proliferative impact of nifedipine, AGS cell viability was calculated employing the XTT assay across a concentration range of 25, 50, 100, 200, and 500 µg/mL. Concurrently, TAS and TOS kits were employed to evaluate the drug's influence on oxidative stress levels. Nifedipine exhibited a concentration-dependent cytotoxic effect on AGS cells, with a statistically significant reduction in cell viability. The IC50 value for AGS cells after 24 hours was determined to be 98.49 µg/mL. At this concentration, a substantial augmentation in TOS and a concurrent diminution in TAS levels were observed relative to the control group. These observations imply that nifedipine-induced oxidative stress is one of the mechanisms underlying its cytotoxic action against gastric cancer cells. Our results highlight the potential therapeutic utility of nifedipine in this cancer type.
- 30 December 2024
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 45 (4) , 683-687
Open AccessOxidative Stress Mediates Anti-proliferative Effects of Nifedipine on AGS Cells
Previous studies have demonstrated the anticancer properties of certain calcium channel blockers when administered as sole agents. This exploration aimed to explore the potential anti-proliferative activity of nifedipine on AGS gastric cancer cells and to determine the contribution of oxidative stress in mediating this response. To assess the anti-proliferative impact of nifedipine, AGS cell viability was calculated employing the XTT assay across a concentration range of 25, 50, 100, 200, and 500 µg/mL. Concurrently, TAS and TOS kits were employed to evaluate the drug's influence on oxidative stress levels. Nifedipine exhibited a concentration-dependent cytotoxic effect on AGS cells, with a statistically significant reduction in cell viability. The IC50 value for AGS cells after 24 hours was determined to be 98.49 µg/mL. At this concentration, a substantial augmentation in TOS and a concurrent diminution in TAS levels were observed relative to the control group. These observations imply that nifedipine-induced oxidative stress is one of the mechanisms underlying its cytotoxic action against gastric cancer cells. Our results highlight the potential therapeutic utility of nifedipine in this cancer type.
- 29 October 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (4) , 4631-4640
Enoxaparin Protects C6 Glioma Cells from Glutamate-Induced Cytotoxicity by Reducing Oxidative Stress and Apoptosis
Recent studies suggest enoxaparin may protect the central nervous system (CNS) from damage. However, its specific effects on glial cells and the underlying mechanisms involving cell death and oxidative stress require further investigation. Therefore, this research investigated enoxaparin’s potential to safeguard C6 glioma cells against glutamate-induced cytotoxicity, specifically focusing on its influence on oxidative stress and apoptotic mechanisms. To investigate the neuroprotective effects of enoxaparin against glutamate-induced cytotoxicity in C6 cells, four groups were established: a control group, a group exposed to 10 mM glutamate, a group treated with enoxaparin at concentrations ranging from 25 to 200 µM, and a group receiving both 10 mM glutamate and enoxaparin at concentrations ranging from 25 to 200 µM. Cell viability was measured using an XTT assay. To evaluate the effects of enoxaparin on oxidative stress, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were measured using ELISA, along with total antioxidant status (TAS) and total oxidant status (TOS). Apoptosis was evaluated using flow cytometry, and caspase-3 activity, a key marker of apoptosis, was assessed using caspase-3 immunofluorescence staining. Enoxaparin at 50, 100, and 200 µM markedly increased cell viability in the enoxaparin + glutamate group. Enoxaparin treatment in the enoxaparin + glutamate group also significantly elevated levels of SOD and TAS, while concurrently decreasing MDA and TOS levels. These changes indicate a reduction in oxidative stress. Enoxaparin treatment further resulted in a significant decline in cleaved caspase-3 levels, a marker of apoptosis. Enoxaparin pre-treatment reduced cell death according to flow cytometry analysis. This study suggests enoxaparin’s potential to shield C6 glioma cells from glutamate-induced cell death by mitigating both oxidative stress and apoptotic pathways. More research is needed to confirm this effect. Graphical Abstract
- 29 October 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (4) , 4631-4640
Enoxaparin Protects C6 Glioma Cells from Glutamate-Induced Cytotoxicity by Reducing Oxidative Stress and Apoptosis
Recent studies suggest enoxaparin may protect the central nervous system (CNS) from damage. However, its specific effects on glial cells and the underlying mechanisms involving cell death and oxidative stress require further investigation. Therefore, this research investigated enoxaparin’s potential to safeguard C6 glioma cells against glutamate-induced cytotoxicity, specifically focusing on its influence on oxidative stress and apoptotic mechanisms. To investigate the neuroprotective effects of enoxaparin against glutamate-induced cytotoxicity in C6 cells, four groups were established: a control group, a group exposed to 10 mM glutamate, a group treated with enoxaparin at concentrations ranging from 25 to 200 µM, and a group receiving both 10 mM glutamate and enoxaparin at concentrations ranging from 25 to 200 µM. Cell viability was measured using an XTT assay. To evaluate the effects of enoxaparin on oxidative stress, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were measured using ELISA, along with total antioxidant status (TAS) and total oxidant status (TOS). Apoptosis was evaluated using flow cytometry, and caspase-3 activity, a key marker of apoptosis, was assessed using caspase-3 immunofluorescence staining. Enoxaparin at 50, 100, and 200 µM markedly increased cell viability in the enoxaparin + glutamate group. Enoxaparin treatment in the enoxaparin + glutamate group also significantly elevated levels of SOD and TAS, while concurrently decreasing MDA and TOS levels. These changes indicate a reduction in oxidative stress. Enoxaparin treatment further resulted in a significant decline in cleaved caspase-3 levels, a marker of apoptosis. Enoxaparin pre-treatment reduced cell death according to flow cytometry analysis. This study suggests enoxaparin’s potential to shield C6 glioma cells from glutamate-induced cell death by mitigating both oxidative stress and apoptotic pathways. More research is needed to confirm this effect. Graphical Abstract
- Open Access
- 1 July 2024
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 37 (3) , 233-246
Ferroptosis inhibitor ferrostatin-1 attenuates morphine tolerance development in male rats by inhibiting dorsal root ganglion neuronal ferroptosis
Hasan Dirik, Ahmet Şevki Taşkıran, and Ziad Joha. Korean J Pain 2024;37:233-46. https://doi.org/10.3344/kjp.24042
- 1 July 2024
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 37 (3) , 233-246
Open AccessFerroptosis inhibitor ferrostatin-1 attenuates morphine tolerance development in male rats by inhibiting dorsal root ganglion neuronal ferroptosis
Hasan Dirik, Ahmet Şevki Taşkıran, and Ziad Joha. Korean J Pain 2024;37:233-46. https://doi.org/10.3344/kjp.24042
- Open Access
- 28 December 2023
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 44 (4) , 640-644
Unraveling the Role of Apoptosis in the Antiproliferative Activity of β-Glucan on A549 Cells
Previous studies have reported the anticancer properties of β-glucan on various cancer cells. The objective of this research was to investigate the involvement of apoptosis in the cytotoxic action of β-glucan on the A549 cells. The cytotoxic impact of this drug on A549 cells was examined by subjecting them to various quantities of the substance, and the XTT assay was utilized to determine cell survival. Flow cytometry was performed to investigate apoptosis. A statistically significant and dose-dependent cytotoxic impact on A549 cells was observed upon treatment with β-glucan. The calculated IC50 value of β-glucan for A549 cells after a 24-hour treatment period was discovered to be 82.16 μg/mL. Further investigations carried out using the IC50 dose of β-glucan revealed a significant increase in the late apoptotic cells percentage. The capacity of β-glucan to trigger apoptosis is thought to be the cause of its cytotoxic action on lung cancer. The revelation of this discovery emphasizes the promising possibilities of β-glucan as an effective therapeutic choice.
- 28 December 2023
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 44 (4) , 640-644
Open AccessUnraveling the Role of Apoptosis in the Antiproliferative Activity of β-Glucan on A549 Cells
Previous studies have reported the anticancer properties of β-glucan on various cancer cells. The objective of this research was to investigate the involvement of apoptosis in the cytotoxic action of β-glucan on the A549 cells. The cytotoxic impact of this drug on A549 cells was examined by subjecting them to various quantities of the substance, and the XTT assay was utilized to determine cell survival. Flow cytometry was performed to investigate apoptosis. A statistically significant and dose-dependent cytotoxic impact on A549 cells was observed upon treatment with β-glucan. The calculated IC50 value of β-glucan for A549 cells after a 24-hour treatment period was discovered to be 82.16 μg/mL. Further investigations carried out using the IC50 dose of β-glucan revealed a significant increase in the late apoptotic cells percentage. The capacity of β-glucan to trigger apoptosis is thought to be the cause of its cytotoxic action on lung cancer. The revelation of this discovery emphasizes the promising possibilities of β-glucan as an effective therapeutic choice.
- Open Access
- 30 September 2023
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 11 (9) , 1686-1692
Hidrojen Peroksit ile İndüklenen C6 Hücrelerinde Oksidatif Stres Kaynaklı Apoptosis ve İnflamatuar Artışına Karşı Astaksantinin Koruyucu Etkisi
Recent findings have indicated the potential protective impacts of astaxanthin on the central nervous system (CNS). Nevertheless, the precise influence of astaxanthin on oxidative damage caused by hydrogen peroxide (H2O2) in glial cells, as well as its interplay with apoptotic and inflammatory mechanisms, remain unclear. As a result, the primary goal of this study was to explore how astaxanthin functions as a safeguard against glial cell damage induced by oxidative stress triggered by H2O2, particularly focusing on its involvement in inflammatory and apoptotic pathways. The study employed C6 glioma cells as the experimental model. Cells in the H2O2 group were subjected to hydrogen peroxide (H2O2) treatment for 24 hours. In the astaxanthin group, cells were treated with varying concentrations of astaxanthin for 24 hours. For the astaxanthin + H2O2 group, cells were first pre-treated with different concentrations of astaxanthin for 1 hour and subsequently exposed to H2O2 for 24 hours. The XTT assay was utilized to evaluate cell viability. To demonstrate the antioxidative effect, total oxidant status (TOS) and total antioxidant status (TAS) measurements were conducted TNF-α and IL-1β levels were assessed using the ELISA method to measure anti-inflammatory effect. ELISA was also employed to measure the anti-apoptotic effect, involving the measurement of caspase 3, BAX, and Bcl-2 levels. In the group treated with both astaxanthin and H2O2, astaxanthin exhibited a notable increase in cell viability within C6 cells. Additionally, it significantly elevated the levels of TAS while decreasing the levels of TOS, indicative of reduced oxidative stress. Furthermore, astaxanthin demonstrated a significant reduction in inflammatory markers, including TNF-α and IL-1β levels. Moreover, it led to a substantial decrease in apoptotic markers, specifically cleaved caspase-3 and Bax, while simultaneously increasing the levels of the anti-apoptotic protein Bcl-2. Astaxanthin demonstrates protective properties by engaging anti-inflammatory and anti-apoptotic pathways, countering the oxidative stress induced by hydrogen peroxide in C6 glioma cells. However, a more comprehensive investigation is required to address the potential underlying mechanisms.
- 30 September 2023
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 11 (9) , 1686-1692
Open AccessHidrojen Peroksit ile İndüklenen C6 Hücrelerinde Oksidatif Stres Kaynaklı Apoptosis ve İnflamatuar Artışına Karşı Astaksantinin Koruyucu Etkisi
Recent findings have indicated the potential protective impacts of astaxanthin on the central nervous system (CNS). Nevertheless, the precise influence of astaxanthin on oxidative damage caused by hydrogen peroxide (H2O2) in glial cells, as well as its interplay with apoptotic and inflammatory mechanisms, remain unclear. As a result, the primary goal of this study was to explore how astaxanthin functions as a safeguard against glial cell damage induced by oxidative stress triggered by H2O2, particularly focusing on its involvement in inflammatory and apoptotic pathways. The study employed C6 glioma cells as the experimental model. Cells in the H2O2 group were subjected to hydrogen peroxide (H2O2) treatment for 24 hours. In the astaxanthin group, cells were treated with varying concentrations of astaxanthin for 24 hours. For the astaxanthin + H2O2 group, cells were first pre-treated with different concentrations of astaxanthin for 1 hour and subsequently exposed to H2O2 for 24 hours. The XTT assay was utilized to evaluate cell viability. To demonstrate the antioxidative effect, total oxidant status (TOS) and total antioxidant status (TAS) measurements were conducted TNF-α and IL-1β levels were assessed using the ELISA method to measure anti-inflammatory effect. ELISA was also employed to measure the anti-apoptotic effect, involving the measurement of caspase 3, BAX, and Bcl-2 levels. In the group treated with both astaxanthin and H2O2, astaxanthin exhibited a notable increase in cell viability within C6 cells. Additionally, it significantly elevated the levels of TAS while decreasing the levels of TOS, indicative of reduced oxidative stress. Furthermore, astaxanthin demonstrated a significant reduction in inflammatory markers, including TNF-α and IL-1β levels. Moreover, it led to a substantial decrease in apoptotic markers, specifically cleaved caspase-3 and Bax, while simultaneously increasing the levels of the anti-apoptotic protein Bcl-2. Astaxanthin demonstrates protective properties by engaging anti-inflammatory and anti-apoptotic pathways, countering the oxidative stress induced by hydrogen peroxide in C6 glioma cells. However, a more comprehensive investigation is required to address the potential underlying mechanisms.